newsfilter
← Latest News
Business Wire·

Protembis Announces Completion of € 30 Million Series B Financing Round and the Addition of Keith D Dawkins MD to the Board of Directors

Financing and Reinforcement of Board of Directors Builds Momentum in Readiness for the Initiation of the IDE Pivotal Trial Protembis GmbH (Protembis), a privately-held emerging cardiovascular medical device company,